What is the prognosis for a live birth after unexplained recurrent implantation failure following IVF/ICSI?

被引:25
|
作者
Koot, Y. E. M. [1 ]
Saxtorph, M. Hviid [2 ]
Goddijn, M. [3 ]
de Bever, S. [3 ]
Eijkemans, M. J. C. [1 ,4 ]
von Wely, M. [3 ]
van der Veen, F. [3 ]
Fauser, B. C. J. M. [1 ]
Macklon, N. S. [1 ,2 ,5 ]
机构
[1] Univ Med Ctr Utrecht, Dept Reprod Med & Gynaecol, Utrecht, Netherlands
[2] Zealand Univ Hosp, Dept Obstet & Gynaecol, Sygehusvej 10, DK-4000 Roskilde, Denmark
[3] Univ Amsterdam, Amsterdam Univ, Ctr Reprod Med, Med Ctr, Amsterdam, Netherlands
[4] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[5] London Womens Clin, London, England
关键词
recurrent implantation failure; IVF; ICSI; pregnancy; prognosis; EMBRYO; COUPLES; FERTILIZATION; PATHOLOGY; MODELS; RATES; LIFE;
D O I
10.1093/humrep/dez120
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
STUDY QUESTION: What is the cumulative incidence of live birth and mean time to pregnancy (by conception after IVF/ICSI or natural conception) in women experiencing unexplained recurrent implantation failure (RIF) following IVF/ICSI treatment? SUMMARY ANSWER: In 118 women who had experienced RIF, the reported cumulative incidence of live birth during a maximum of 5.5 years follow-up period was 49%, with a calculated median time to pregnancy leading to live birth of 9 months after diagnosis of RIF. WHAT IS KNOWN ALREADY: Current definitions of RIF include failure to achieve a pregnancy following IVF/ICSI and undergoing three or more fresh embryo transfer procedures of one or two high quality embryos or more than 10 embryos transferred in fresh or frozen cycles. The causes and optimal management of this distressing condition remain uncertain and a range of empirical and often expensive adjuvant therapies is often advocated. Little information is available regarding the long-term prognosis for achieving a pregnancy. STUDY DESIGN, SIZE, DURATION: Two hundred and twenty-three women under 39 years of age who had experienced RIF without a known cause after IVF/ICSI treatment in two tertiary referral university hospitals between January 2008 and December 2012 were invited to participate in this retrospective cohort follow up study. PARTICIPANTS/MATERIALS, SETTING, METHODS: All eligible women were sent a letter requesting their consent to the anonymous use of their medical file data and were asked to complete a questionnaire enquiring about treatments and pregnancies subsequent to experiencing RIF. Medical files and questionnaires were examined and results were analysed to determine the subsequent cumulative incidence of live birth and time to pregnancy within a maximum 5.5 year follow-up period using Kaplan Meier analysis. Clinical predictors for achieving a live birth were investigated using a Cox hazard model. MAIN RESULTS AND THE ROLE OF CHANCE: One hundred and twenty-seven women responded (57%) and data from 118 women (53%) were available for analysis. During the maximum 5.5 year follow up period the overall cumulative incidence of live birth was 49% (95% CI 39-59%). Among women who gave birth, the calculated median time to pregnancy was 9 months after experiencing RIF, where 18% arose from natural conceptions. LIMITATIONS, REASONS FOR CAUTION: Since only 57% of the eligible study cohort completed the questionnaire, the risk of response bias limits the applicability of the study findings. WIDER IMPLICATIONS OF THE FINDINGS: This study reports a favorable overall prognosis for achieving live birth in women who have previously experienced RIF, especially in those who continue with further IVF/ICSI treatments. However since 51 % did not achieve a live birth during the follow-up period, there is a need to distinguish those most likely to benefit from further treatment In this study, no clinical factors were found to be predictive of those achieving a subsequent live birth.
引用
收藏
页码:2044 / 2051
页数:8
相关论文
共 50 条
  • [1] Prognosis for ongoing pregnancy after recurrent implantation failure (RIF) following IVF/ICSI treatment
    Brentjens, L. Stevens
    Roumen, R.
    Romano, A.
    Van Golde, R.
    Den Hartog, J.
    [J]. HUMAN REPRODUCTION, 2023, 38
  • [2] Aspirin and heparin to improve live birth rate in IVF for unexplained implantation failure?
    Clark, David A.
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2013, 26 (06) : 538 - 541
  • [3] Analysis of IVF/ICSI Outcomes in Endometriosis Patients With Recurrent Implantation Failure: Influence on Cumulative Live Birth Rate
    Zhong, Chenyi
    Gao, Liusijie
    Shu, Li
    Hou, Zhen
    Cai, Lingbo
    Huang, Jie
    Liu, Jiayin
    Mao, Yundong
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [4] IVF prognosis after recurrent implantation failure: Experience of German centers
    Kling, C.
    Schmutzler, A.
    Wilke, G.
    Hedderich, J.
    Kabelitz, D.
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 (05) : 505 - 511
  • [5] A New Innovative Method to Increase Live Birth Rate in Case of Previous Unexplained Repeated Embryo Implantation Failure after intra-conjugal IVF/ICSI or oocyte donation
    Ledee, N.
    Petitbarat, M.
    Rahmati, M.
    Turki, F.
    Methni, A.
    Balet, R.
    Dubanchet, S.
    Chevrier, L.
    Gahery, H.
    Wezmar, K.
    Bensussan, A.
    Chaouat, G.
    [J]. HUMAN REPRODUCTION, 2015, 30 : 255 - 256
  • [6] Aspirin and heparin as adjuvants during IVF do not improve live birth rates in unexplained implantation failure
    Akhtar, Muhammad A.
    Eljabu, Hanan
    Hopkisson, James
    Raine-Fenning, Nick
    Quenby, Siobhan
    Jayaprakasan, Kannamannadiar
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2013, 26 (06) : 586 - 594
  • [7] Live birth in women previously experiencing recurrent implantation failure upon IVF: a retrospective cohort study
    Koot, Y. E. M.
    de Bever, S.
    Goddijn, M.
    Eijkemans, M. C. J.
    van Wely, M.
    van der Veen, F.
    Fauser, B. C. J. M.
    Macklon, N. S.
    [J]. HUMAN REPRODUCTION, 2015, 30 : 121 - 121
  • [8] Day after rescue ICSI: eliminating total fertilization failure after conventional IVF with high live birth rates following cryopreserved blastocyst transfer
    Batha, Sara
    Ardestani, Goli
    Ocali, Olcay
    Jarmuz, Pam
    Vaughan, Denis A.
    Barrett, C. Brent
    Sakkas, Denny
    [J]. HUMAN REPRODUCTION, 2023, 38 (07) : 1277 - 1283
  • [9] Pregnancy outcome and live birth after IVF and ICSI according to embryo quality
    Fauque, Patricia
    Leandri, Roger
    Merlet, Francoise
    Juillard, Jean-Claude
    Epelboin, Sylvie
    Guibert, Juliette
    Jouannet, Pierre
    Patrat, Catherine
    [J]. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2007, 24 (05) : 159 - 165
  • [10] Pregnancy outcome and live birth after IVF and ICSI according to embryo quality
    Patricia Fauque
    Roger Léandri
    Françoise Merlet
    Jean-Claude Juillard
    Sylvie Epelboin
    Juliette Guibert
    Pierre Jouannet
    Catherine Patrat
    [J]. Journal of Assisted Reproduction and Genetics, 2007, 24 : 159 - 165